Cure CF Columbus
Trainee Award Program
Request for Applications (2022-2023)
The grant includes two trainee fellowships. The purpose of this RFA is to support highly meritorious trainee projects. These applications can be an extension of prior funded C3 Research projects or new proposals from any eligible OSU or NCH trainee.
- Up to $25,000 can be used for partial stipend support, supplies, core services, animal costs, travel, etc.
- For trainees with prior C3 support, a second year of funding is contingent on demonstration of satisfactory progress and approval by the C3 Research Internal and External Advisory Boards. A separate budget and justification will be required at this stage.
- No indirect costs will be provided.
|
RFA Release date: February 1, 2022
Grant Application Deadline: April 4, 2022 at 5pm |
Award Notifications: June 2022
Earliest Project Start Date: July 1, 2022 |
Templates:
Cure CF Columbus
Pilot & Feasibility Award
Request for Applications (2022-2023)
Basic Science P&F Projects:
Funding of individual basic science P&F studies cannot extend beyond two years. Year 1 funding ($40,000) will be provided by C3 after completion of the review process. The second year of funding ($40,000) is contingent upon submission and approval of a renewal progress report and the availability of funds. No indirect costs will be provided.
Translational P&F Projects:
These projects seek to apply basic scientific knowledge to a clinical problem, acquire basic knowledge from clinical specimens, or examine the feasibility of a therapeutic approach in an appropriate animal model or with appropriate clinical specimens. Translational P&F projects may receive funding for up to two years. Year 1 funding ($60,000) will be provided by C3 after completion of the review process. Year 2 funding ($60,000) is contingent upon submission and approval of a renewal progress report and the availability of funds. No indirect costs will be provided.
Translational P&F projects may not subject human volunteers to experimental medicines, devices or techniques; obtain clinical specimens prospectively unless such specimens are collected as a part of routine patient care; or make use of Health Insurance Portability and Accountability Act-protected confidential patient information.
Direct costs may be requested for:
Funding of individual basic science P&F studies cannot extend beyond two years. Year 1 funding ($40,000) will be provided by C3 after completion of the review process. The second year of funding ($40,000) is contingent upon submission and approval of a renewal progress report and the availability of funds. No indirect costs will be provided.
Translational P&F Projects:
These projects seek to apply basic scientific knowledge to a clinical problem, acquire basic knowledge from clinical specimens, or examine the feasibility of a therapeutic approach in an appropriate animal model or with appropriate clinical specimens. Translational P&F projects may receive funding for up to two years. Year 1 funding ($60,000) will be provided by C3 after completion of the review process. Year 2 funding ($60,000) is contingent upon submission and approval of a renewal progress report and the availability of funds. No indirect costs will be provided.
Translational P&F projects may not subject human volunteers to experimental medicines, devices or techniques; obtain clinical specimens prospectively unless such specimens are collected as a part of routine patient care; or make use of Health Insurance Portability and Accountability Act-protected confidential patient information.
Direct costs may be requested for:
- Salary support
- Research supplies
- Equipment
- Research-related subject costs
- Consultant costs
- Support for multidisciplinary collaborations, including travel
- Travel costs for scientific/technical meeting(s)
|
RFA Release date: February 1, 2022
Grant Application Deadline: April 4, 2022 at 5pm |
Award Notifications: June 2022
Earliest Project Start Date: July 1, 2022 |
Templates:
Cure CF Columbus
Trainee Award Program
Phase 3 Request for Applications (2019-2020)
The call for applications is now closed.
Award Notification: Late February, 2020